Bacterial isolates Drugs tested No(%) resistance No CRO CIP TE C E DO P CN TMP-STX AMP OXA S. pneumoniae 20 NA NA 10 (50) 1 (5) 1 (5) NA NA NA 1 (5) NA 12 (60) S. aureus 18 4 (22.2) 4 (22.2) 18 (100) 5 (27.8) 9 (50) 9 (50) 15 (83.3) 5  (27.8) 15 (83.3) 15 (83.3) 15 (83.3) P. aeruginosa 12 1 (8.3) 1 (8.3) NA NA NA NA NA 7 (58.3) NA NA NA K. pneumoniae 11  0 0 11 (100) 2 (18.2) NA 1 (9.1) NA 2 (18.2) 11 (100) 11 (100) NA P. mirabilis 2 1 (50) 1 (50) 2 (100) 2 (100) NA 2 (100) NA 2 (100) 2 (100) 2 (100) NA P. vulgaris 1 0 0 1 1 NA 1 NA 1 1 1 NA E. coli 5 0 0 5 (100) 5 (100) NA 5 (100) NA 1 (20) 5 (100) 5 (100) NA H. influenzae 4 1 (25) 1 (25) 4 (100) 1 (25) NA NA NA NA 4 (100) 2 (50) NA Total 73 7 (13.2) 7 (13.2) 51(83.6) 18 (29.5) 10 (26.3) 18 (48.6) 15 (83.3) 18 (36.7) 39 (63.9) 36 (87.8) 27 (71.1)

Note:  NA- Not applicable, CRO- Ceftriaxone, CIP- Ciprofloxacin, TE- Tetracycline, C- Chloramphenicol, E-Erythromycin, DO- Doxycycline, P- Penicillin, CN- Gentamycin, TMP-STX- Trimethoprim-sulfamethoxazole, AMP- Ampicillin and OXA- Oxacillin

Table 2: Drug resistance pattern of bacterial isolates from adult patients with Community-acquired pneumonia in Arba Minch Hospital, 2013